EUVIMEDEUVIMED entdecken
Open Access · CC BYNC 4.0

Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries

Chanjoo Khan, Hocheol Shin, Eunyoung Kim

Research in Clinical Pharmacy · 2023

DOI: 10.59931/rcp.23.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2023. Verfasst von Chanjoo Khan und 2 weiteren Autor:innen. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BYNC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Ministry of Education.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to analyze autologous and allogeneic cell therapies.A gap analysis of source-cell storage regulations and guidelines of allogeneic cell therapies was performed for regulatory authorities in target countries, including the USA, EU, Japan, and Korea.

Methods

Cell-storage regulations and guidelines regarding allogeneic cell therapy products framed by regulatory authorities were comparatively analyzed.

Results

Of 41 cell therapies, 10 allogeneic cell therapies were selected, and their source cells were categorized based on 3 types of cell storage, namely cell bank (n=6) in the USA, Japan, and Korea; cell stock (n=2) in the EU; and drug substance (n=2) in Korea.In the gap analysis of cell storage regulations and guidelines by the selected regulatory authorities, cell storage systems have regulations and guidelines similar to those stipulated by regulatory authorities, except for the regulation of source-cell changes.Most allogeneic cell therapies used cell banks for cell storage.Thus, to ensure the safety of allogeneic cell therapy, more detailed criteria must be established for source-cell changes in cell storage systems.

Conclusion

Regulatory authorities can ensure a safer and more effective supply of therapy products to the public by harmonizing the regulations associated with allogeneic cell therapies.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • Ministry of Education

Zitieren

APA

Khan, C., Shin, H., & Kim, E. (2023). Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.23.006

Vancouver

Khan C, Shin H, Kim E. Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries. Research in Clinical Pharmacy. 2023. doi:10.59931/rcp.23.006

BibTeX
@article{Khan2023,
  author = {Khan, Chanjoo and Shin, Hocheol and Kim, Eunyoung},
  title = {Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries},
  journal = {Research in Clinical Pharmacy},
  year = {2023},
  doi = {10.59931/rcp.23.006}
}
Kostenlos starten →